Five rare variants in <i>BRIP1/FANCJ</i>, initially identified in ovarian cancer (OC) or breast cancer (BC) cases by the adult hereditary cancer clinics, were investigated for their candidacy as clinically relevant variants. The gene discussed is BRIP1; the disease is ovarian cancer.